Advanced Search

Oncology & Hematology Coding Alert

Reader Questions:

Reconsider Code Choice When Recurrent Dx Questionable

Published on Mon Jul 26, 2021

Question: A patient who received treatment from our provider for endometrial cancer two years ago returned to our practice, and our provider documented recurrent endometrial adenocarcinoma to the vaginal cuff, stage 1A. Do I document this as metastatic process of endometrial to the vaginal cuff (C79.82) given that it’s recurring at the vaginal cuff, or should it be documented as [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All